The Effect of Transcutaneous Electrical Nerve Stimulation (TENS) Application on Patients' Undergoing Hip Replacement
1 other identifier
interventional
60
1 country
1
Brief Summary
The surgical treatment of an individual with osteoarthritis and hip fracture is provided by hip replacement surgery. While restructuring the joint surfaces with surgery, it is aimed to provide both hip joint movements and to treat pain. Intense perioperative pain after hip replacement is common due to inflammatory agents and surgical intervention (eg, involvement of soft tissue and sensory nerves). Inadequately treated acute postoperative pain causes longer hospital stay, limited and delayed bed rest, decreased compliance with physical therapy, and an increased incidence of postoperative complications. It is thought that this method, which can be effective in the pain control of the patient, will be beneficial for the patient both physiologically and psychologically by reducing pain and discomfort. The most important advantage of TENS; It can be easily applied by nurses and easily taught to patients or families. The nurse has a great role in the follow-up of the patient after the surgery, as she/ he is with the patient for 24 hours. When the literature is examined, it is seen that the number of studies showing the effectiveness of TENS application in patients who underwent hip prosthesis, where studies were conducted with patients with knee gonarthrosis, is limited. In this direction, the aim of the study is to examine the effect of TENS application on patients' pain level and analgesic use in patients undergoing hip replacement.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 3, 2023
CompletedFirst Posted
Study publicly available on registry
July 11, 2023
CompletedStudy Start
First participant enrolled
November 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2025
CompletedSeptember 26, 2024
July 1, 2024
6 months
July 3, 2023
September 24, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in the pain level using the VAS.
Reducing the pain level of patients undergoing hip replacement by applying TENS. A value of 0 on the scale means that the patient does not experience pain, and a value of 10 means that he experiences pain at the most severe level
48 hour
Change in analgesic consumption
Changing analgesic consumption of patients by applying TENS. The analgesic consumption in the first 2 days after the surgery will be learned by using the questionnaire.
48 hour
Study Arms (2)
TENS group
EXPERIMENTAL60 minutes of TENS will be applied to the experimental group on the 0th and 1st days after the surgery, and the pain assessment at the time of movement/rest before and after the procedure will be made by the researcher. After the procedure, the amount of analgesic consumed by the experimental group in the first hour will be questioned and recorded.
Control group
NO INTERVENTIONThe routine treatment and care of the control group will not be interfered with.
Interventions
TENS will be applied to the experimental group on the 0th and 1st days after the surgery, and the pain assessment at the time of movement/rest before and after the procedure will be made by the researcher.
Eligibility Criteria
You may qualify if:
- be over 18 years old
- hip replacement insertion
- not have a pacemaker or arrhythmia
- no history of pain, alcohol use or substance abuse
- no history of pain, alcohol use or substance abuse
- no history of pain, alcohol use or substance abuse
- no history of psychiatric illness
- no history of metastatic disease
- being conscious, able to speak
- No barriers to the application of TENS; no postoperative complications
- being I, II and III in the ASA classification of the American Society of Anesthesiology, agreeing to participate in the study.
You may not qualify if:
- having a history of epilepsy
- Using analgesics at least 1 hour before TENS is applied
- the presence of a wound in the area where the electrode will be placed.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cukurova University
Adana, Adana, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Açelya Türkmen, PhD
Cukurova University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
July 3, 2023
First Posted
July 11, 2023
Study Start
November 1, 2024
Primary Completion
May 1, 2025
Study Completion
September 1, 2025
Last Updated
September 26, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share